1205狼疮患者对COVID-19疫苗的看法

R. Sadun, A. Eudy, Jennifer L Rogers, K. Sun, Karissa Grier, E. Scarlett, Mithu Maheswaranathan, Lisa G. Criscione-Schreiber, J. Doss, M. Clowse
{"title":"1205狼疮患者对COVID-19疫苗的看法","authors":"R. Sadun, A. Eudy, Jennifer L Rogers, K. Sun, Karissa Grier, E. Scarlett, Mithu Maheswaranathan, Lisa G. Criscione-Schreiber, J. Doss, M. Clowse","doi":"10.1136/lupus-2021-lupus21century.72","DOIUrl":null,"url":null,"abstract":"1205 Figure 1Respondents indicated which factors would have a positive influence on their likelihood of getting vaccinated against COVID-19;more than two-thirds of respondents indicated they would be more likely to pursue vaccination if they were presented with evidence of COVID-19 vaccine safety in lupus.[Figure omitted. See PDF]ConclusionsThese results indicate an opportunity for healthcare professionals and patient advocacy organizations to assuage unfounded patient concerns, such as vaccine interactions with medications or food allergies being a contraindication to COVID-19 vaccination, while reassuring patients that vaccine-triggered flares are rare.AcknowledgementWe would like to thank the Lupus Foundation of American for their partnership in this research.","PeriodicalId":263566,"journal":{"name":"1200 - COVID-19","volume":"137 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"1205 COVID-19 vaccine beliefs amongst individuals living with lupus\",\"authors\":\"R. Sadun, A. Eudy, Jennifer L Rogers, K. Sun, Karissa Grier, E. Scarlett, Mithu Maheswaranathan, Lisa G. Criscione-Schreiber, J. Doss, M. Clowse\",\"doi\":\"10.1136/lupus-2021-lupus21century.72\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1205 Figure 1Respondents indicated which factors would have a positive influence on their likelihood of getting vaccinated against COVID-19;more than two-thirds of respondents indicated they would be more likely to pursue vaccination if they were presented with evidence of COVID-19 vaccine safety in lupus.[Figure omitted. See PDF]ConclusionsThese results indicate an opportunity for healthcare professionals and patient advocacy organizations to assuage unfounded patient concerns, such as vaccine interactions with medications or food allergies being a contraindication to COVID-19 vaccination, while reassuring patients that vaccine-triggered flares are rare.AcknowledgementWe would like to thank the Lupus Foundation of American for their partnership in this research.\",\"PeriodicalId\":263566,\"journal\":{\"name\":\"1200 - COVID-19\",\"volume\":\"137 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"1200 - COVID-19\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/lupus-2021-lupus21century.72\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"1200 - COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2021-lupus21century.72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

1205图1受访者指出了哪些因素会对他们接种COVID-19疫苗的可能性产生积极影响;超过三分之二的受访者表示,如果他们得到COVID-19疫苗对狼疮安全的证据,他们更有可能接种疫苗。(图省略。这些结果表明,医疗保健专业人员和患者倡导组织有机会缓解患者毫无根据的担忧,例如疫苗与药物相互作用或食物过敏是COVID-19疫苗接种的禁忌症,同时让患者放心,疫苗引发的症状很少发生。我们要感谢美国狼疮基金会在这项研究中的合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
1205 COVID-19 vaccine beliefs amongst individuals living with lupus
1205 Figure 1Respondents indicated which factors would have a positive influence on their likelihood of getting vaccinated against COVID-19;more than two-thirds of respondents indicated they would be more likely to pursue vaccination if they were presented with evidence of COVID-19 vaccine safety in lupus.[Figure omitted. See PDF]ConclusionsThese results indicate an opportunity for healthcare professionals and patient advocacy organizations to assuage unfounded patient concerns, such as vaccine interactions with medications or food allergies being a contraindication to COVID-19 vaccination, while reassuring patients that vaccine-triggered flares are rare.AcknowledgementWe would like to thank the Lupus Foundation of American for their partnership in this research.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信